Phase I study investigating the safety and feasibility of combining imatinib mesylate (Gleevec) with sorafenib in patients with refractory castration-resistant prostate cancer
about
Recent progress in pharmaceutical therapies for castration-resistant prostate cancerBone-induced c-kit expression in prostate cancer: a driver of intraosseous tumor growth.Ageing is a risk factor in imatinib mesylate cardiotoxicityInefficiencies and Patient Burdens in the Development of the Targeted Cancer Drug Sorafenib: A Systematic ReviewImatinib and prostate cancer: lessons learned from targeting the platelet-derived growth factor receptor.Novel therapeutic approaches for the treatment of castration-resistant prostate cancer.Paradoxical and contradictory effects of imatinib in two cell line models of hormone-refractory prostate cancer.The stem cell factor (SCF)/c-KIT signalling in testis and prostate cancer.Retrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancer.
P2860
Q27022567-8A4C653F-128A-4C80-BA5D-8314181D236DQ34353130-674F4D77-725C-45B5-9DF4-DA826E9EAF28Q34548719-CFA4A20B-2699-4765-834C-4357527BB606Q36270115-99C0260D-267D-433A-A707-E607F9D5C502Q38094296-FBC40517-0504-4774-A7BF-8D8CF626A758Q38116358-A2DF541E-32EC-4E91-B478-315A873734EAQ38897955-66B3497A-F6ED-4D7C-9C35-B63A268DC4DFQ39401758-0CAE7549-B2E2-4888-AF54-ABBBF6C42F01Q42530532-A8E3FE95-80F4-4F24-90AF-EAB3BE0CF1C1
P2860
Phase I study investigating the safety and feasibility of combining imatinib mesylate (Gleevec) with sorafenib in patients with refractory castration-resistant prostate cancer
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Phase I study investigating th ...... tion-resistant prostate cancer
@ast
Phase I study investigating th ...... tion-resistant prostate cancer
@en
type
label
Phase I study investigating th ...... tion-resistant prostate cancer
@ast
Phase I study investigating th ...... tion-resistant prostate cancer
@en
prefLabel
Phase I study investigating th ...... tion-resistant prostate cancer
@ast
Phase I study investigating th ...... tion-resistant prostate cancer
@en
P2093
P2860
P356
P1476
Phase I study investigating th ...... tion-resistant prostate cancer
@en
P2093
D Villines
J D Bitran
J H Beumer
M J Egorin
S M Christner
T M Lestingi
T V Valdez
P2860
P2888
P304
P356
10.1038/BJC.2012.312
P407
P577
2012-07-17T00:00:00Z
P5875
P6179
1032750595